Search - tctmd.com

Displaying 201 - 220 of 349

Sort: Relevancy | Date

News Industry News

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

November 24, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Yael L. Maxwell

November 19, 2013

Presentation TCT 2013

Pro Position: FREEDOM was the Final Nail in the Coffin!

Presenter: Duane Pinto

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Conference News TCT 2013

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

October 31, 2013

Presentation TCT 2013

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

Presenter: Vasim Farooq

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

News Industry News

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

Presenter: David Taggart

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Presenter: George Dangas

October 27, 2013

Presentation TCT 2013

FREEDOM: Essential results

Presenter: Michael Farkouh

October 27, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

Advertisement

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Pro Position: FREEDOM was the Final Nail in the Coffin!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

PCI vs. CABG a Close Call in Some Complex Patients

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

Intraprocedural ST Predicts Adverse Short-Term Events

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

FREEDOM: Essential results

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content